Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology

CA London, H Gardner, S Zhao… - Veterinary and …, 2023 - Wiley Online Library
Pet dogs develop spontaneous cancers at a rate estimated to be five times higher than that
of humans, providing a unique opportunity to study disease biology and evaluate novel …

Cross-species oncogenic signatures of breast cancer in canine mammary tumors

TM Kim, IS Yang, BJ Seung, S Lee, D Kim… - Nature …, 2020 - nature.com
Genomic and precision medicine research has afforded notable advances in human cancer
treatment, yet applicability to other species remains uncertain. Through whole-exome and …

Translational oncotargets for immunotherapy: From pet dogs to humans

LA Mestrinho, RR Santos - Advanced Drug Delivery Reviews, 2021 - Elsevier
Preclinical studies in rodent models have been a pivotal role in human clinical research, but
many of them fail in the translational process. Spontaneous tumors in pet dogs have the …

Losartan blocks osteosarcoma-elicited monocyte recruitment, and combined with the kinase inhibitor toceranib, exerts significant clinical benefit in canine metastatic …

DP Regan, L Chow, S Das, L Haines, E Palmer… - Clinical Cancer …, 2022 - AACR
Purpose: There is increasing recognition that progress in immuno-oncology could be
accelerated by evaluating immune-based therapies in dogs with spontaneous cancers …

Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma

S Das, R Idate, DP Regan, JS Fowles, SE Lana… - Communications …, 2021 - nature.com
Abstract Osteosarcoma affects about 2.8% of dogs with cancer, with a one-year survival rate
of approximately 45%. The purpose of this study was to characterize mutation and …

Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions

S Das, R Idate, SE Lana, DP Regan, DL Duval - Scientific Reports, 2023 - nature.com
Soft tissue sarcomas (STS) are a heterogenous group of mesenchymal tumors representing
over 50 distinct types with overlapping histological features and non-specific anatomical …

The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations

K Megquier, J Turner-Maier, K Morrill, X Li, J Johnson… - Plos one, 2022 - journals.plos.org
The characterization of immortalized canine osteosarcoma (OS) cell lines used for research
has historically been based on phenotypic features such as cellular morphology and …

[HTML][HTML] Genomic tumor analysis provides clinical guidance for the management of diagnostically challenging cancers in dogs

E Chon, G Wang, D Whitley… - Journal of the …, 2023 - Am Vet Med Assoc
Schematic of steps taken for the use of a genomic assay (SearchLight DNA; Vidium Animal
Health) in identifying and annotating mutations occurring within a tumor. This genomic assay …

A domestic cat whole exome sequencing resource for trait discovery

AR Rodney, RM Buckley, RS Fulton, C Fronick… - Scientific reports, 2021 - nature.com
Over 94 million domestic cats are susceptible to cancers and other common and rare
diseases. Whole exome sequencing (WES) is a proven strategy to study these disease …

Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs

BR Wei, CJ Peer, WJ Richardson, SM Hewitt… - Frontiers in Veterinary …, 2022 - frontiersin.org
Activation of one or both the Ras/MAPK and PI3K/Akt/mTOR signal transduction pathways
are known to mediate oncogenicity of several canine and human cancers, including …